Spirometer Market Size to Exceed USD 2,600.5 Mn by 2032

The Spirometer Market, estimated at USD 1,377.7 Mn in 2025, is expected to exhibit a CAGR of 9.5% and reach USD 2,600.5 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

The key market players are focusing on the research and development of technologically advanced spirometers, which is expected to drive the global spirometer market growth. For instance, in September 2025, My Music Machines Inc., a U.S.-based small scale company, initiated a study entitled “A Randomized Control Trial of ZEPHYRx Gamified Incentive Spirometry Compared to Traditional Spirometry,” which compares the efficacy of ZEPHYRx incentive spectrometer with standard incentive spirometer. The study was launched in collaboration with University of Rochester, New York, U.S.

Global Spirometer Market - Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spread quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

The COVID-19 pandemic significantly impacted the global spirometer market. While there was an initial surge in the demand for spirometers to assess respiratory health, disruptions in supply chains and healthcare priorities shifted focus away from non-essential medical equipment. Consequently, the market experienced temporary setbacks in production and distribution.

However, the pandemic also underscored the importance of respiratory monitoring, driving long-term growth as healthcare systems recognized the need for enhanced respiratory diagnostics and management. This led to increased investments in spirometry technology, telemedicine solutions, and home-based monitoring, ultimately reshaping the market and fostering innovation in the post-pandemic era. For instance, in June 2025, Inofab Health, a startup company that has developed the ultrasonic spirometer, Spirohome, received a strategic investment of US$ 15 Mn from ERT, a company that focuses on respiratory diseases clinical research technologies, and Karel, a Turkey-based electronics producer.

Global Spirometer Market: Key Developments

In April 2025, StatPearls, a comprehensive medical database for healthcare practitioners, published a study entitled “Incentive Spirometer and Inspiratory Muscle Training.” The study highlights the correct use of incentive spirometer in inspiratory muscle training.

 In September 2025, Biosensors and Bioelectronics, a peer-reviewed scientific journal, published a study entitled “A portable triboelectric spirometer for wireless pulmonary function monitoring.” The study discusses practical design of the self-powered flow spirometer which can be a low-cost alternative for pulmonary function testing.

In April 2025, Respiratory Research, an open access peer-reviewed medical journal, published a study entitled “Design and Development of Smartphone-Enabled Spirometer with a Disease Classification System Using Convolutional Neural Network.” The study summarizes the design and development of a low-cost, portable, and smartphone-enabled spirometer with an automatic disease classification system.

Browse 38 Market Data Tables and 28 Figures spread through 180 Pages and in-depth TOC on “Global Spirometer Market”- Forecast to 2032, Global Spirometer Market, By Product Type (Hand Held, Table Top, and Desktop), By Technology Type (Volume Measurement, Flow Measurement, and Peak Flow Measurement), By Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Pulmonary Fibrosis, and Others (Emphysema, Chronic Bronchitis, and Bronchiectasis)), By End User (Hospitals and Clinics, and Home Healthcare), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)  

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/spirometer-market-2615

Key Takeaways of the Global Spirometer Market:

• The global spirometer market is expected to exhibit a CAGR of 9.5% during the forecast period. Increasing research and development in the field of spirometry is expected to drive the market growth. For instance, in March 2025, Pediatric Pulmonology, a monthly peer-reviewed medical journal covering pediatric pulmonology, published a study entitled “Comparison of a handheld turbine spirometer to conventional spirometry in children with cystic fibrosis.” The study validates accuracy of an entirely handheld turbine spirometer vs a standard laboratory device in pediatric cystic fibrosis patients.
• Among application, the chronic obstructive pulmonary disease segment is expected to hold the dominant position in the global spirometer market during the forecast period due to the growing prevalence of chronic obstructive pulmonary disease. For instance, a 2025 report in the European Respiratory Journal projected that the global mean prevalence of chronic obstructive pulmonary disease was roughly 13.1% in 2025, up from 11.7% in 2010, and that this prevalence was increasing globally.
• Among region, North America is expected to be the dominant region in the global spirometer market owing to the increasing adoption of inorganic growth strategies, such as acquisition and partnership, by key market players. For instance, in June 2025, MGC Diagnostics, a U.S.-based medical technology company, announced a global distribution agreement with Monitored Therapeutics, Inc., a remote patient monitoring company. MGC Diagnostics will expand its respiratory care product portfolio by distributing GoSpiro, a spirometer manufactured by Monitored Therapeutics, Inc.
• The major players operating in the global spirometer market are Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, Aluna, and Welch Allyn